News

Deal Announcements

ARYx Therapeutics Nets $2 Million Venture Capital Debt

Tuesday, August 31, 2010 5:57:00 AM PDT | VentureDeal Staff
Fremont, California  --  Pharmaceutical company ARYx Therapeutics has received a little over $2 million in venture capital debt, according to a regulatory filing.

ARYx Therapeutics says that it is developing "intellectual property in the area of retrometabolic drug design."

Investors in the financing were not disclosed, nor was how the company intends to use the financing proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1